Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Spyre Therapeutics Inc.
Swot
Spyre Therapeutics Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Spyre Therapeutics Inc. has 9 Strengths, 7 Weaknesses, 1 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(9)
Weakness
(7)
Opportunity
(1)
Threats
(2)
Others
(1)
Rising Momentum: Momentum Score Weekly Gainers
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over the Quarter (3 Months)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Increasing profits every quarter for the past 2 quarters
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Top Losers
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Top Losers
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Decreased Shareholding in Past Month
MFs decreased their shareholding last quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
